GPCR
-
AstraZeneca, Heptares to investigate important GPCR drug targets
AstraZeneca and Heptares Therapeutics announced they have entered a four-year collaboration focused on the potential discovery and development of new medicines targeting G-protein coupled receptors (GPCRs). GPCRs are among the largest and most imp…
GPCR | 31 May 2011
-
GVK Biosciences Announces Agreement with University of Tokyo on GPCR Database
GVK Biosciences has entered into an agreement with Dr Kimito Funatsu, University of Tokyo on G-protein Coupled Receptor (GPCR) databases. The agreement covers the GPCR class of targets curated at the company. Dr Funatsu will utilize the manually …
GPCR | 02 July 2009
